Influenza A: Understanding the viral life cycle

Yale Journal of Biology and Medicine

Volumn 82, Issue 4, 2009, Pages 153-159

  Samji, Tasleem ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cap snatching; HA; Hemagglutinin; Host shut off; Influenza A; M1; M2; NA; NEP; NP; NS1; NS2; PA; PB1; PB1 F2; PB2; Sialic acid; Virus

Indexed keywords

CELL BUDDING; CELL MEMBRANE; CELL NUCLEUS; GENOME; HOST CELL; INFLUENZA VIRUS A; LIFE CYCLE; NONHUMAN; ORTHOMYXOVIRUS; SHORT SURVEY; VIRUS ENTRY; VIRUS GENE; VIRUS GENOME; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; RIBONUCLEOPROTEINS; VIRUS ASSEMBLY; VIRUS INTERNALIZATION;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 74049096170     PISSN: 00440086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (60)

1. Fields BN, Knipe DM, Howley PM. Fields virology. Philadelphia: Wolters Kluwer Health/LippincottWilliams & Wilkins; 2007.
2. Scheiffele P, Rietveld A, Wilk T, Simons K. Influenza viruses select ordered lipid domains during budding from the plasma membrane. J Biol Chem. 1999;274(4):2038-44.
3. Zhang J, Pekosz A, Lamb RA. Influenza virus assembly and lipid raft microdomains: a role for the cytoplasmic tails of the spike glycoproteins. J Virol. 2000;74(10):4634-44.
4. Nayak DP, Balogun RA, Yamada H, Zhou ZH, Barman S. Influenza virus morphogenesis and budding. Virus Res. 2009;143(2):147-61.
5. Schroeder C, Heider H, Moncke-Buchner E, Lin TI. The influenza virus ion channel and maturation cofactorM2 is a cholesterol-binding protein. Eur Biophys J. 2005;34(1):52-66.
6. Nayak DP, Hui EK, Barman S. Assembly and budding of influenza virus. Virus Res. 2004;106(2):147-65.
7. Skehel JJ, Wiley DC. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem. 2000;69:531-69.
8. Huang Q, Sivaramakrishna RP, Ludwig K, Korte T, Bottcher C, Herrmann A. Early steps of the conformational change of influenza virus hemagglutinin to a fusion active state: stability and energetics of the hemagglutinin. Biochim Biophys Acta. 2003;1614(1):3-13.
9. Holsinger LJ, Lamb RA. Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds. Virology.1991;183(1): 32-43.
10. Pinto LH, Holsinger LJ, Lamb RA. Influenza virus M2 protein has ion channel activity. Cell. 1992;69(3):517-28.
11. Pinto LH, Lamb RA. The M2 proton channels of influenza A and B viruses. J Biol Chem. 2006;281(14):8997-9000.
12. Boulo S, Akarsu H, Ruigrok RW, Baudin F. Nuclear traffic of influenza virus proteins and ribonucleoprotein complexes. Virus Res. 2007;124(1-2):12-21.
13. Crow M, Deng T, Addley M, Brownlee GG. Mutational analysis of the influenza virus cRNA promoter and identification of nucleotides critical for replication. J Virol. 2004;78(12):6263-70.
14. Deng T, Vreede FT, Brownlee GG. Different de novo initiation strategies are used by influenza virus RNA polymerase on its cRNA and viral RNA promoters during viral RNA replication. J Virol. 2006;80(5):2337-48.
15. Flick R, Neumann G, Hoffmann E, Neumeier E, Hobom G. Promoter elements in the influenza vRNA terminal structure. RNA. 1996;2(10):1046-57.
16. Azzeh M, Flick R, Hobom G. Functional analysis of the influenzaAvirus cRNApromoter and construction of an ambisense transcription system. Virology. 2001;289(2):400-10.
17. Plotch SJ, Tomasz J, Krug RM. Absence of detectable capping and methylating enzymes in influenza virions. J Virol. 1978;28(1):75-83.
18. Krug RM, Morgan MA, Shatkin AJ. Influenza viral mRNA contains internal N6-methyladenosine and 5'-terminal 7-methylguanosine in cap structures. J Virol. 1976;20(1):45-53.
19. Dhar R, Chanock RM, Lai CJ. Nonviral oligonucleotides at the 5' terminus of cytoplasmic influenza viral mRNAdeduced from cloned complete genomic sequences. Cell. 1980;21(2):495-500.
20. Bouloy M, Plotch SJ, Krug RM. Globin mRNAs are primers for the transcription of influenza viral RNAin vitro. Proc NatlAcad Sci USA. 1978;75(10):4886-90.
21. Plotch SJ, Bouloy M, Krug RM. Transfer of 5'-terminal cap of globin mRNAto influenza viral complementary RNA during transcription in vitro. Proc Natl Acad Sci USA. 1979;76(4):1618-22.
22. Plotch SJ, BouloyM, Ulmanen I, Krug RM.A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription. Cell.1981;23(3):847-58.
23. Bouloy M, Morgan MA, Shatkin AJ, Krug RM. Cap and internal nucleotides of reovirus mRNA primers are incorporated into influenza viral complementary RNA during transcription in vitro. J Virol. 1979;32(3):895-904.
24. Bouloy M, Plotch SJ, Krug RM. Both the 7-methyl and the 2'-O-methyl groups in the cap of mRNA strongly influence its ability to act as primer for influenza virus RNA transcription. Proc Natl Acad Sci USA. 1980;77(7):3952-6.
25. Krug RM, Broni BA, Bouloy M. Are the 5' ends of influenza viral mRNAs synthesized in vivo donated by host mRNAs? Cell. 1979;18(2):329-34.
26. Robertson HD, Dickson E, Plotch SJ, Krug RM. Identification of the RNA region transferred from a representative primer, beta-globin mRNA, to influenza mRNA during in vitro transcription. Nucleic Acids Res. 1980;8(5):925-42.
27. Li ML, Rao P, Krug RM. The active sites of the influenza cap-dependent endonuclease are on different polymerase subunits. EMBO J. 2001;20(8):2078-86.
28. Engelhardt OG, Smith M, Fodor E. Association of the influenzaAvirus RNA-dependent RNA polymerase with cellular RNA polymerase II. J Virol. 2005;79(9):5812-8.
29. Amorim MJ, Digard P. Influenza A virus and the cell nucleus. Vaccine. 2006;24(44-46):6651-5.
30. Engelhardt OG, Fodor E. Functional association between viral and cellular transcription during influenza virus infection. Rev Med Virol. 2006;16(5):329-45.
31. LuY, Qian XY, Krug RM. The influenza virus NS1 protein: a novel inhibitor of pre-mRNA splicing. Genes Dev. 1994;8(15):1817-28.
32. Wang W, Krug RM. U6atac snRNA, the highly divergent counterpart of U6 snRNA, is the specific target that mediates inhibition ofAT-AC splicing by the influenza virus NS1 protein. RNA. 1998;4(1):55-64.
33. Fortes P, Lamond AI, Ortin J. Influenza virus NS1 protein alters the subnuclear localization of cellular splicing components. J Gen Virol. 1995;76(Pt 4):1001-7.
34. Wolff T, O'Neill RE, Palese P. NS1-Binding protein (NS1-BP): a novel human protein that interacts with the influenza A virus nonstructural NS1 protein is relocalized in the nuclei of infected cells. JVirol. 1998;72(9):7170-80.
35. Momose F, Basler CF, O'Neill RE, Iwamatsu A, Palese P, Nagata K. Cellular splicing factor RAF-2p48/NPI-5/BAT1/UAP56 interacts with the influenza virus nucleoprotein and enhances viral RNA synthesis. J Virol. 2001;75(4):1899-908.
36. Fodor E, Pritlove DC, Brownlee GG. The influenza virus panhandle is involved in the initiation of transcription. JVirol. 1994;68(6):4092-6.
37. Hagen M, Chung TD, Butcher JA, Krystal M. Recombinant influenza virus polymerase: requirement of both 5' and 3' viral ends for endonuclease activity. J Virol. 1994;68(3):1509-15.
38. Robertson JS, Schubert M, Lazzarini RA. Polyadenylation sites for influenza virus mRNA. J Virol. 1981;38(1):157-63.
39. Poon LL, Fodor E, Brownlee GG. Polyuridylated mRNA synthesized by a recombinant influenza virus is defective in nuclear export. J Virol. 2000;74(1):418-27.
40. Poon LL, Pritlove DC, Fodor E, Brownlee GG. Direct evidence that the poly(A) tail of influenzaAvirus mRNAis synthesized by reiterative copying of a U track in the virion RNA template. J Virol. 1999;73(4):3473-6.
41. Shimizu K, Iguchi A, Gomyou R, Ono Y. Influenza virus inhibits cleavage of the HSP70 pre-mRNAs at the polyadenylation site. Virology. 1999;254(2):213-9.
42. Nemeroff ME, Barabino SM, LiY, Keller W, Krug RM. Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular premRNAs. Mol Cell. 1998;1(7):991-1000.
43. Chen Z, Li Y, Krug RM. Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3'-end processing machinery. EMBO J. 1999;18(8):2273-83.
44. Shapiro GI, Gurney T Jr., Krug RM. Influenza virus gene expression: control mechanisms at early and late times of infection and nuclear-cytoplasmic transport of virus-specific RNAs. J Virol. 1987;61(3):764-73.
45. Akarsu H, Burmeister WP, Petosa C, Petit I, Muller CW, Ruigrok RW, Baudin F. Crystal structure of the M1 protein-binding domain of the influenzaAvirus nuclear export protein (NEP/NS2). EMBO J. 2003;22(18):4646-55.
46. Baudin F, Petit I, Weissenhorn W, Ruigrok RW. In vitro dissection of the membrane and RNP binding activities of influenza virusM1 protein. Virology. 2001;281(1):102-8.
47. Loucaides EM, von Kirchbach JC, Foeglein A, Sharps J, Fodor E, Digard P. Nuclear dynamics of influenza A virus ribonucleoproteins revealed by live-cell imaging studies. Virology. 2009;394(1):154-63.
48. Elton D, Amorim MJ, Medcalf L, Digard P. 'Genome gating'; polarized intranuclear trafficking of influenza virus RNPs. Biol Lett. 2005;1(2):113-7.
49. Iwatsuki-Horimoto K, Horimoto T, Noda T, Kiso M, Maeda J, Watanabe S, et al. The cytoplasmic tail of the influenza A virus M2 protein plays a role in viral assembly. J Virol. 2006;80(11):5233-40.
50. Burleigh LM, Calder LJ, Skehel JJ, Steinhauer DA. Influenza a viruses with mutations in the m1 helix six domain display a wide variety of morphological phenotypes. J Virol. 2005;79(2):1262-70.
51. Chen BJ, Lamb RA. Mechanisms for enveloped virus budding: can some viruses do without an ESCRT? Virology. 2008;372(2):221-32.
52. Enami M, Sharma G, Benham C, Palese P. An influenza virus containing nine different RNA segments. Virology. 1991;185(1):291-8.
53. Bancroft CT, Parslow TG. Evidence for segment-nonspecific packaging of the influenza a virus genome. J Virol. 2002;76(14):7133-9.
54. Smith GL, Hay AJ. Replication of the influenza virus genome. Virology. 1982;118(1):96-108.
55. Fujii Y, Goto H, Watanabe T, Yoshida T, Kawaoka Y. Selective incorporation of influenza virus RNA segments into virions. Proc NatlAcad Sci USA. 2003;100(4):2002-7.
56. Muramoto Y, Takada A, Fujii K, Noda T, Iwatsuki-Horimoto K,Watanabe S, et al. Hierarchy among viral RNA(vRNA) segments in their role in vRNA incorporation into influenza A virions. J Virol. 2006;80(5):2318-25.
57. Watanabe T, Watanabe S, Noda T, Fujii Y, KawaokaY. Exploitation of nucleic acid packaging signals to generate a novel influenza virus-based vector stably expressing two foreign genes. J Virol. 2003;77(19):10575-83.
58. Liang Y, Hong Y, Parslow TG. cis-Acting packaging signals in the influenza virus PB1, PB2, and PA genomic RNA segments. J Virol. 2005;79(16):10348-55.
59. Fujii K, FujiiY, Noda T, Muramoto Y, Watanabe T, Takada A, et al. Importance of both the coding and the segment-specific noncoding regions of the influenza A virus NS segment for its efficient incorporation into virions. J Virol. 2005;79(6):3766-74.
60. Palese P, Tobita K, Ueda M, Compans RW. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology. 1974;61(2):397-410.